Novel Tx for Binge-Eating Cuts Weight in Obese Adults
Dasotraline, a novel binge eating disorder treatment, helped reduce body weight in a secondary analysis, a researcher reported at Psych Congress 2019.After 12 weeks, the once-daily investigational long-acting dopamine/norepinephrine reuptake inhibitor was associated with a significant 12.57 lb (5.7 kg) reduction in body weight compared with a 0.88 lb (0.4 kg) gain in placebo, according to Leslie Citrome, MD, of New York Medical College in Valhalla. Study participants on dasotra
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies